Literature DB >> 25016051

Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin.

Reza Homayounfar1, Mahmood Jeddi-Tehrani2, Makan Cheraghpour3, Asghar Ghorbani4, Hamid Zand5.   

Abstract

This paper aimed to explore the role of p53 in adipose and some other peripheral tissues of a diet-induced obese model and targeted it using pharmacological approach to ameliorate diet-induced insulin resistance. Five week old male Wistar rats were randomly divided into three groups and fed on low-fat diet (13% control lean group), high-fat diet (41% obese group), or high-fat diet plus a single dose of pifithrin-α in the end of experiments (PFT group). Insulin, glucose, and other serum parameters were analyzed by standard colorimetric kits. Protein levels were evaluated by immunoblotting and immunofluorescence methods. After 12weeks, both body weight and insulin resistance were significantly higher in obese rats than in the control ones. P53 and PTEN protein levels were markedly elevated in peripheral tissues in addition to adipose tissues. AKT activation was decreased in the peripheral tissues of obese rats and was in correlation with the increase of p53 and PTEN level. Systemic pifithrin-α administration considerably diminished p53 levels and ameliorated AKT phosphorylation in all peripheral tissues including adipose tissues. Interestingly, the systemic inhibition of p53 was in correlation with improving insulin glucose at serum level. The present results clearly showed that p53 activation in peripheral tissues was in correlation with decreased insulin action. These results indicated p53 activation in the peripheral tissues of obese subjects as a protective mechanism against chronic insulin elevation, suggested that p53 could be a new target for the treatment of type 2 diabetes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet-induced obesity; Insulin resistance; Pifithrin-α; p53

Mesh:

Substances:

Year:  2014        PMID: 25016051     DOI: 10.1016/j.ygcen.2014.06.029

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  10 in total

1.  Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.

Authors:  Seo Rin Kim; Kai Jiang; Mikolaj Ogrodnik; Xiaojun Chen; Xiang-Yang Zhu; Hannah Lohmeier; Leena Ahmed; Hui Tang; Tamara Tchkonia; LaTonya J Hickson; James L Kirkland; Lilach O Lerman
Journal:  Transl Res       Date:  2019-07-15       Impact factor: 7.012

Review 2.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

3.  Hepatocyte p53 ablation induces metabolic dysregulation that is corrected by food restriction and vertical sleeve gastrectomy in mice.

Authors:  Marlena M Holter; Darline Garibay; Seon A Lee; Mridusmita Saikia; Anne K McGavigan; Lily Ngyuen; Elizabeth S Moore; Erin Daugherity; Paul Cohen; Kathleen Kelly; Robert S Weiss; Bethany P Cummings
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.191

4.  Ability of dairy fat in inducing metabolic syndrome in rats.

Authors:  Sayed Hossein Davoodi; Hamid Zand; Alireza Askari; Seyed Amin Kouhpayeh; Elham Ehrampoush; Reza Homayounfar
Journal:  Springerplus       Date:  2016-11-28

Review 5.  Is p53 Involved in Tissue-Specific Insulin Resistance Formation?

Authors:  Justyna Strycharz; Jozef Drzewoski; Janusz Szemraj; Agnieszka Sliwinska
Journal:  Oxid Med Cell Longev       Date:  2017-01-17       Impact factor: 6.543

6.  Tumour protein 53 is linked with type 2 diabetes mellitus.

Authors:  Agnieszka Sliwinska; Jacek Kasznicki; Marcin Kosmalski; Melania Mikolajczyk; Aneta Rogalska; Karolina Przybylowska; Ireneusz Majsterek; Jozef Drzewoski
Journal:  Indian J Med Res       Date:  2017-08       Impact factor: 2.375

Review 7.  Control of metabolism by p53 - Cancer and beyond.

Authors:  Christiaan F Labuschagne; Fabio Zani; Karen H Vousden
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-06-05       Impact factor: 10.680

Review 8.  The p53/Adipose-Tissue/Cancer Nexus.

Authors:  Kevin Zwezdaryk; Deborah Sullivan; Zubaida Saifudeen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-14       Impact factor: 5.555

Review 9.  Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.

Authors:  Matthieu Lacroix; Romain Riscal; Giuseppe Arena; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Metab       Date:  2019-10-18       Impact factor: 7.422

10.  P53/PANK1/miR-107 signalling pathway spans the gap between metabolic reprogramming and insulin resistance induced by high-fat diet.

Authors:  Lu Yang; Bin Zhang; Xinju Wang; Zhenhua Liu; Juan Li; Shumiao Zhang; Xiaoming Gu; Min Jia; Haitao Guo; Na Feng; Rong Fan; Manjiang Xie; Jianming Pei; Li Chen
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.